Previous close | 0.0050 |
Open | 0.0020 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0004 - 0.0020 |
52-week range | 0.0001 - 1.6600 |
Volume | |
Avg. volume | 2,552,163 |
Market cap | 171,895 |
Beta (5Y monthly) | 1.52 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 13 May 2024 - 19 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.30 |
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024.
Invitae (OTC: NVTA), a leading medical genetics company, today published its 2024 Environmental, Social and Governance (ESG) Report. This report provides a holistic view of the company's approach to ESG and its performance and progress through measurable data and metrics during the 2023 fiscal year.